Literature DB >> 27095814

Diagnosis of a rare fetal haemoglobinopathy in the age of next-generation sequencing.

Thomas A Hooven1, Ellen M Hooper2, Sandeep N Wontakal3, Richard O Francis3, Rakesh Sahni2, Margaret T Lee2.   

Abstract

Neonatal cyanosis resulting from a fetal methaemoglobin variant is rare. Most such variants are only described in a few published case reports. We present the case of a newborn with unexplained persistent cyanosis, ultimately determined to have a γ-chain mutation causing Hb FM-Fort Ripley. This neonatal haemoglobinopathy can be challenging to diagnose, as significant oxygen desaturation may result from barely detectable levels of the mutant haemoglobin and co-oximetry studies may show a falsely normal methaemoglobin level. Our analysis of the infant's haemoglobin included high-performance liquid chromatography, cellulose acetate electrophoresis and citrate agar electrophoresis, which showed trace amounts of a suspected variant. Ultimately, the diagnosis was made through a novel application of next-generation sequencing (NGS). NGS-based diagnostic approaches are becoming increasingly available to clinicians, and our case provides a framework and evidence for the utilisation of such testing paradigms in the diagnosis of a rare cause of neonatal cyanosis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27095814      PMCID: PMC4840678          DOI: 10.1136/bcr-2016-215193

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Hb FM-Fort Ripley: confirmation of autosomal dominant inheritance and diagnosis by PCR and direct nucleotide sequencing.

Authors:  R D Hain; D Chitayat; R Cooper; E Bandler; B Eng; D H Chui; J S Waye; M H Freedman
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

2.  Mutant fetal hemoglobin causing cyanosis in a newborn.

Authors:  J R Priest; J Watterson; R T Jones; A E Faassen; B E Hedlund
Journal:  Pediatrics       Date:  1989-05       Impact factor: 7.124

Review 3.  Methemoglobinemia: etiology, pharmacology, and clinical management.

Authors:  R O Wright; W J Lewander; A D Woolf
Journal:  Ann Emerg Med       Date:  1999-11       Impact factor: 5.721

4.  Laboratory assessment of oxygenation in methemoglobinemia.

Authors:  Shannon Haymond; Rohit Cariappa; Charles S Eby; Mitchell G Scott
Journal:  Clin Chem       Date:  2004-10-28       Impact factor: 8.327

5.  A second observation of the fetal methemoglobin variant Hb F-M-Fort Ripley or alpha 2G gamma 2(92)(F8)His----Tyr.

Authors:  T P Molchanova; J B Wilson; L H Gu; R D Hain; L S Chang; A O Poon; T H Huisman
Journal:  Hemoglobin       Date:  1992       Impact factor: 0.849

Review 6.  Neonatal polycythemia and hyperviscosity.

Authors:  Shikha Sarkar; Ted S Rosenkrantz
Journal:  Semin Fetal Neonatal Med       Date:  2008-08       Impact factor: 3.926

7.  Measurement of methemoglobin in neonatal samples containing fetal hemoglobin.

Authors:  E D Speakman; J C Boyd; D E Bruns
Journal:  Clin Chem       Date:  1995-03       Impact factor: 8.327

8.  Neonatal cyanosis due to a novel fetal hemoglobin: Hb F-Circleville [Ggamma63(E7)His-->Leu, CAT>CTT].

Authors:  Erin Dainer; Richard Shell; Randy Miller; Joan F Atkin; Matt Pastore; Abdullah Kutlar; Lina Zhuang; Leslie Holley; Debra H Davis; Ferdane Kutlar
Journal:  Hemoglobin       Date:  2008       Impact factor: 0.849

9.  Evaluation and management of the cyanotic neonate.

Authors:  Robin H Steinhorn
Journal:  Clin Pediatr Emerg Med       Date:  2008-09

10.  Hemoglobin F-Cincinnati, alpha 2G gamma 2 41(C7) Phe-->Ser in a newborn with cyanosis.

Authors:  M Kohli-Kumar; T Zwerdling; D L Rucknagel
Journal:  Am J Hematol       Date:  1995-05       Impact factor: 10.047

View more
  1 in total

1.  Case report of congenital methemoglobinemia: an uncommon cause of neonatal cyanosis.

Authors:  Allison N J Lyle; Rebecca Spurr; Danielle Kirkey; Catherine M Albert; Zeenia Billimoria; Jose Perez; Mihai Puia-Dumitrescu
Journal:  Matern Health Neonatol Perinatol       Date:  2022-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.